Table 1 The role of main biochemistry substances in OA
Names | Receptors | Roles | References |
|---|---|---|---|
Substance P (SP) | Neurokinin 1 receptor (NK1R) | Promote angiogenesis in the subchondral bone; contribute to cartilage degradation and synovial inflammation; mediate joint pain | |
Prostaglandin E2 (PGE2) | Prostaglandin E (EP) 1–4 receptors | Disturb subchondral bone remodeling; promote innervation in the subchondral bone; regulate chondrocytes metabolism; mediate joint pain | |
Nerve growth factor (NGF) | Tropomyosin receptor kinase A (TrkA) | Promote vascular and nerve growth in the subchondral bone; mediate hyperalgesia of OA synovium; mediate mechanical load-induced pain | |
Transforming growth factor (TGF)-β | TGF-β receptor 1–3 | Contribute to cartilage degeneration; lead to aberrant bone formation accompanied by increased angiogenesis | |
Calcitonin-gene-related peptide (CGRP) | Calcitonin receptor-like receptor (CRLR)/ receptor activity modifying protein (RAMP) 1 | Promote apoptosis and senescence of chondrocytes; inhibit the expression of chondrogenic markers | |
α-melanocyte-stimulating hormone (α-MSH) | Melanocorticosteroid receptor 1 (MC1R) | Inhibit inflammation in the synovium and cartilage; play a chondroprotective role in cartilage | |
Platelet-derived BB growth factor (PDGF-BB) | Platelet-derived growth factor receptor (PDGFR)-α; PDGFR-β | Induce abnormal angiogenesis and bone remodeling in OA subchondral bone | |
Norepinephrine (NE) or noradrenaline (NA) | α1, α2, β1, β2, β3-adrenergic receptor (AR) | Protect cartilage from degeneration (β-AR); inhibit subchondral bone formation (β2-AR); induce the apoptosis of chondrocytes (α1-AR); inhibit the chondrogenic differentiation of synovial adipose stem cell (α2- AR) | |
Vasoactive intestinal peptide (VIP) | Vasoactive intestinal peptide receptor (VIPR) 1, 2 | Inhibit cartilage extracellular matrix (ECM) degradation; alleviates OA via inhibiting NF-κB signaling pathway | |
Neuropeptide Y (NPY) | Y receptor 1 (Y1R); Y2R; Y4R; Y5R | Increases in OA synovial fluid and correlate to Watanabe pain scores; increases in dorsal root ganglion (DRG) of OA; exacerbate the OA progression | |
Serotonin (5-HT) | 5-HT 1-7 receptors | Repress cartilage regeneration; promote chondrocyte inflammation |